Patented nano-informational peptides isolated through proprietary ultra-nanofiltration technology. Engineered to cross the blood-brain barrier, stimulate central immune regulation, and competitively inhibit viral docking. Clinically proven broad spectrum antiviral & immunity (+) booster.
The Inventor of the World's 1st AIKAT Virtual Hospital. Globally patented medical informatics systems integrating artificial intelligence knowledge acquisition tools for rapid diagnostics, telemedicine, and distributed clinical drug trials.
Translating sustainable biological raw materials into cost-effective therapeutic solutions.
Formulated from mammalian colostrum via molecular exclusion technology to provide broad-spectrum antiviral and immunomodulatory activity.
Evaluated across clinical trials and meta-analyses encompassing 25,301 subjects across HIV, influenza, allergies, and autoimmune indications.
Backed by product and process patents across 58 therapeutic indications in the United States, Europe, South Africa, and international jurisdictions.
ISO 22000 Registered Company : Rigorous commitment to international safety and quality standards across all facilities.
cGMP manufacturing infrastructure validated and certified by TUV Nord-Germany.
Historical development support and collaboration from the Department of Science & Technology (DST), Government of India.
